Lead optimisation of dehydroemetine for repositioned use in malaria
P. Panwar, K. Burusco, M. Abubaker, H. Matthews, A. Gutnov, E. Fernandez-Alvaro, R. Bryce, J. Wilkinson, N. J. Nirmalan
This paper optimizes 2,3-dehydroemetine for repositioned use in malaria by showing its potency against P. falciparum and lack of cardiotoxicity.
bioRxiv · Feb 1, 2019Microbiology